Cargando…

Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients

BACKGROUND: Colistin is a last-line defense therapy against extensively drug-resistant Acinetobacter baumannii (XDR-AB). Despite a loading dose of colistin being applied in many clinical practices, studies evaluating the effect of the loading dose of colistin in cancer patients remain limited. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katip, Wasan, Uitrakul, Suriyon, Oberdorfer, Peninnah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593398/ https://www.ncbi.nlm.nih.gov/pubmed/28919792 http://dx.doi.org/10.2147/IDR.S144314

Ejemplares similares

Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
por: Katip, Wasan, et al.
Publicado: (2021)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
por: Katip, Wasan, et al.
Publicado: (2020)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A. baumannii in Cancer Patient
por: Katip, Wasan, et al.
Publicado: (2021)

Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae
por: Katip, Wasan, et al.
Publicado: (2021)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
por: Katip, Wasan, et al.
Publicado: (2021)

Comparative Safety and Effectiveness of Heterologous CoronaVac–ChAdOx1 versus Homologous CoronaVac Vaccination in a Real-World Setting: A Retrospective Cohort Study
por: Ruenkham, Ayakarn, et al.
Publicado: (2023)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
por: Katip, Wasan, et al.
Publicado: (2021)

The Thirty-Day Mortality Rate and Nephrotoxicity Associated With Trough Serum Vancomycin Concentrations During Treatment of Enterococcal Infections: A Propensity Score Matching Analysis
por: Katip, Wasan, et al.
Publicado: (2022)

A Pilot Study of Antibiotic Regimens for Infections Caused by Acinetobacter baumannii in a Secondary Hospital in Thailand
por: Suphansatit, Ronnawich, et al.
Publicado: (2020)

Influence of Concentration and Temperature on Stability of Imipenem Focused on Solutions for Extended Infusion
por: Sornsuvit, Chuleegone, et al.
Publicado: (2021)

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
por: Trebosc, Vincent, et al.
Publicado: (2019)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin
por: Chen, FuMei, et al.
Publicado: (2019)

Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
por: Saelim, Weerayuth, et al.
Publicado: (2021)

A risk scoring system for predicting Streptococcus suis hearing loss: A 13-year retrospective cohort study
por: Rayanakorn, Ajaree, et al.
Publicado: (2020)

Clinical Manifestations and Risk Factors of Streptococcus suis Mortality Among Northern Thai Population: Retrospective 13-Year Cohort Study
por: Rayanakorn, Ajaree, et al.
Publicado: (2019)

Factors Predicting Practices in Prevention of COVID-19 and Impacts among Population in Chiang Mai, Thailand
por: Kasatpibal, Nongyao, et al.
Publicado: (2022)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
por: Sun, Bingbing, et al.
Publicado: (2020)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii
por: Stabile, Maria, et al.
Publicado: (2023)

In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
por: Park, Gyun Cheol, et al.
Publicado: (2016)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
por: Percin, Duygu, et al.
Publicado: (2014)

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
por: Mu, Xinli, et al.
Publicado: (2016)

Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
por: Da Silva, Gabriela Jorge, et al.
Publicado: (2017)

Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii
por: Boinett, Christine J., et al.
Publicado: (2019)

The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii
por: Seleim, Shaimaa Mohamed, et al.
Publicado: (2022)

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
por: Kabic, Jovana, et al.
Publicado: (2022)

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin
por: Álvarez-Marín, Rocío, et al.
Publicado: (2016)

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
por: Gounden, Ronald, et al.
Publicado: (2009)

1824. Combination therapy of daptomycin/colistin for extreme drug resistant Acinetobacter baumannii bacteremia
por: Lampada, Charis, et al.
Publicado: (2022)

Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
por: Kim, Won-Young, et al.
Publicado: (2016)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications
por: Thi Khanh Nhu, Nguyen, et al.
Publicado: (2016)

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
por: Garcia Casallas, Julio Cesar, et al.
Publicado: (2019)

Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_24f1s27rgl6fmhfhf52s8hsc1s